Home » Topics » Regulatory

Regulatory
RSS

FDA approves Imbruvica for marginal zone lymphoma

Jan. 20, 2017

World's only recombinant monovalent acellular Pertussis vaccine receives Thai FDA approval

Dec. 28, 2016

FDA expands indications for Shire's Adynovate

Dec. 28, 2016

FDA grants approval to Spinraza for treatment of spinal muscular atrophy

Dec. 27, 2016

FDA approves Rubraca and companion diagnostic for ovarian cancer

Dec. 20, 2016

BMS's Ximency receives first approval in Japan

Dec. 19, 2016

FDA approves Eucrisa for atopic dermatitis

Dec. 15, 2016

European Commission approves Ferring's Rekovelle

Dec. 14, 2016

FDA approves Avastin for platinum-sensitive ovarian cancer

Dec. 7, 2016

European Commission approves Lucentis for sixth indication

Dec. 7, 2016

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026